Daiichi Sankyo

The Enhertu effect: Daiichi’s plan to build on the success of its crown jewel
Pharma Voice
Fri, 05/10/24 - 11:12 am
Daiichi Sankyo
Enhertu
oncology
Merck
AstraZeneca and Daiichi Sankyo’s Enhertu shows promise in breast cancer trial
Clinical Trials Arena
Mon, 04/29/24 - 11:12 am
AstraZeneca
Daiichi Sankyo
Enhertu
breast cancer
HER2-low breast cancer
FDA grants accelerated approval to Enhertu for metastatic HER2-positive cancers
Investing.com
Sun, 04/7/24 - 04:45 pm
AstraZeneca
Daiichi Sankyo
FDA
Enhertu
solid tumors
Daiichi Sankyo and Merck dose first subject in ovarian cancer trial
Clinical Trials Arena
Thu, 04/4/24 - 10:53 am
Daiichi Sankyo
Merck
ovarian cancer
clinical trials
raludotatug deruxtecan
R-DXd
AZ, Daiichi Sankyo file Dato-DXd for second indication
Pharmaphorum
Tue, 04/2/24 - 11:31 am
AstraZeneca
Daiichi Sankyo
Dato-DXd
breast cancer
Surprise Enhertu rejection follows NICE process change
Pharmaphorum
Tue, 03/5/24 - 11:35 am
AstraZeneca
Daiichi Sankyo
HER2-low breast cancer
Enhertu
NICE
UK
6 first-half 2024 oncology data readouts to watch
BioSpace
Mon, 02/26/24 - 11:20 am
oncology
clinical trials
Daiichi Sankyo
AstraZeneca
Enhertu
metastatic breast cancer
Gilead Sciences
Trodelvy
bladder cancer
GSK
Zejula
Jemperli
ovarian cancer
Roche
tiragolumab
Tecentriq
non-small cell lung cancer
Cue Biopharma
CUE-101
head and neck cancer
Elicio Therapeutics
ELI-002
solid tumors
Daiichi Sankyo and AstraZeneca’s lung cancer antibody set for FDA review
Clinical Trials Arena
Tue, 02/20/24 - 11:30 am
Daiichi Sankyo
AstraZeneca
FDA
Tagrisso
non-small cell lung cancer
Daiichi invests 1 bln eur near Munich to make precision cancer drugs
Reuters
Fri, 02/16/24 - 11:51 am
Daiichi Sankyo
precision medicine
cancer
Germany
Daiichi Sankyo again dials up Enhertu sales forecast, advances 2nd AstraZeneca-partnered ADC
Fierce Pharma
Wed, 01/31/24 - 10:27 pm
Daiichi Sankyo
AstraZeneca
Enhertu
earnings
AstraZeneca, Daiichi aim for first pan-tumor ADC approval
BioPharma Dive
Mon, 01/29/24 - 11:25 am
AstraZeneca
Daiichi Sankyo
antibody-drug conjugate
Enhertu
pan-tumor
FDA
BioNTech challenges AstraZeneca with breast cancer precision drug trial
Reuters
Mon, 01/22/24 - 11:15 am
BioNTech
Duality Biologics
clinical trials
breast cancer
AstraZeneca
Daiichi Sankyo
HER2+ breast cancer
Seagen patent in Daiichi Sankyo ADC dispute nixed by USPTO News
Pharmaphorum
Wed, 01/17/24 - 09:38 am
Seagen
Daiichi Sankyo
patents
legal
Enhertu
USPTO
FDA grants priority review for Daiichi Sankyo-Merck’s lung cancer therapy
Pharmaceutical Business Review
Wed, 12/27/23 - 11:00 pm
Daiichi Sankyo
Merkc
patritumab deruxtecan
FDA
non-small cell lung cancer
Daiichi Sankyo unit claims $182m in Novartis patent dispute
Pharmaphorum
Wed, 12/6/23 - 10:31 am
Daiichi Sankyo
Novartis
Plexxikon
legal
patents
Tafinlar
Japan to buy 1.4 mln doses of Daiichi Sankyo COVID vaccine
Reuters
Thu, 11/16/23 - 10:22 pm
Japan
Daiichi Sankyo
COVID-19
vaccines
Daiichi-Sankyo ups revenue forecast thanks to massive Merck deal
Fierce Biotech
Tue, 10/31/23 - 09:30 pm
Daiichi Sankyo
Merck
antibody-drug conjugate
‘We knew it was there’: AbbVie CEO says company favored internal work over potential Daiichi deal
Fierce Biotech
Sun, 10/29/23 - 08:56 pm
AbbVie
Daiichi Sankyo
Merck
antibody-drug conjugate
ESMO: AstraZeneca-Daiichi get clarity on patient deaths for Enhertu follow up Dato-DXd, survival data still unclear
Fierce Biotech
Mon, 10/23/23 - 05:22 pm
ESMO
Daiichi Sankyo
AstraZeneca
Enhertu
patient deaths
clinical trials
non-small cell lung cancer
Merck pays $4B upfront for rights to 3 Daiichi ADCs in huge bet on post-Keytruda future
Fierce Biotech
Fri, 10/20/23 - 09:55 am
Merck
Daiichi Sankyo
AstraZeneca
antibody-drug conjugate

Pages